EyePoint (EYPT) Assets (2011 - 2026)
EyePoint (EYPT) reported Assets of $288.2 million for Q1 2026, down 20.51% on a YoY basis from $362.6 million in Q1 2025, and down 20.82% sequentially from $364.0 million in Q4 2025.
EyePoint (EYPT) Assets (2011 - 2026) Analysis & Trends
EyePoint (EYPT) has 16 years of Assets data on file, last reported at $288.2 million in Q1 2026.
- For the quarter ending Q1 2026, Assets fell 20.51% year-over-year to $288.2 million; the trailing twelve-month figure through Mar 2026 stood at $288.2 million (down 20.51% YoY), and the FY2025 full-year result was $364.0 million, down 13.02% from the prior year.
- Assets fell to $288.2 million in Q1 2026, from $364.0 million in the prior quarter.
- In the past five years, Assets ranged from a high of $418.5 million in Q4 2024 to a low of $154.6 million in Q1 2023.
- A 5-year average of $274.4 million and a median of $288.2 million in 2026 frame the typical range for Assets.
- Across the five-year window, Assets sank 36.79% in 2023 and jumped 112.98% in 2024, its largest moves.
- Tracing EYPT's Assets over 5 years: stood at $180.4 million in 2022, then jumped by 96.93% to $355.2 million in 2023, then rose by 17.82% to $418.5 million in 2024, then dropped by 13.02% to $364.0 million in 2025, then decreased by 20.82% to $288.2 million in 2026.
- Business Quant data shows EYPT's Assets at $288.2 million in Q1 2026, $364.0 million in Q4 2025, and $251.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 311.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 78.88 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.55 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 39.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.48 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.87 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 811.27 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 10.03 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.25 Bn |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | 288.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 288.22 Mn |
| Dec 31, 2025 | 364.00 Mn |
| Sep 30, 2025 | 251.70 Mn |
| Jun 30, 2025 | 301.15 Mn |
| Mar 31, 2025 | 362.56 Mn |
| Dec 31, 2024 | 418.47 Mn |
| Sep 30, 2024 | 300.92 Mn |
| Jun 30, 2024 | 324.25 Mn |
| Mar 31, 2024 | 329.25 Mn |
| Dec 31, 2023 | 355.18 Mn |
| Sep 30, 2023 | 160.04 Mn |
| Jun 30, 2023 | 175.66 Mn |
| Mar 31, 2023 | 154.59 Mn |
| Dec 31, 2022 | 180.36 Mn |
| Sep 30, 2022 | 220.49 Mn |
| Jun 30, 2022 | 233.43 Mn |
| Mar 31, 2022 | 244.56 Mn |
| Dec 31, 2021 | 263.37 Mn |
| Sep 30, 2021 | 168.25 Mn |
| Jun 30, 2021 | 178.82 Mn |